NASDAQ:IART

Integra Lifesciences Holdings Stock News

etoro logo Buy IART
*Your capital is at risk
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra LifeSciences (IART) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.82 per share a year ago.
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street e
Integra's (IART) Codman Bactiseal EVD lowers financial burdens and guarantees a safe clinical outcome in patients with aSAH-related hydrocephalus.
PRINCETON, N.J., July 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release second quarter 2023 financial r
Integra (IART) announces the completion of patient enrollment in the DuraSorb IDE clinical study.

New Strong Sell Stocks for June 29th

09:08am, Thursday, 29'th Jun 2023
NGVT, IART and BRDG have been added to the Zacks Rank #5 (Strong Sell) List on June 29, 2023.
Investors continue to be optimistic about Integra Lifesciences (IART) based on the prospect of its CSS segment and ample liquidity to support M&A strategies.
Integra announced a global recall of products made at its Boston facility. The company is also temporarily halting production at the facility.
Integra Lifesciences Holdings Corp (NASDAQ:IART) shares fell hard after it disclosed that after consultations with the US Food and Drug Administration (FDA) it has initiated a “voluntary global reca
Integra (IART) opens the Dr. Richard E. Caruso Center of Innovation and Learning in New Jersey.
In CSS, Integra (IART) witnesses a good start to the year with double-digit growth in the CUSA product line and programmable valves as well as strong performance in instrument sales.
Integra LifeSciences (IART) came out with quarterly earnings of $0.74 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.74 per share a year ago.
PRINCETON, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release first quarter 2023 financial r
Integra LifeSciences (IART) delivers strong earnings growth in the fourth quarter amid challenging macro environment issues.
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q4 2022 Earnings Conference Call February 22, 2023 8:30 AM ET Company Participants Chris Ward - Senior Director, Investor Relations Jan De Witt
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE